ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,476Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 5176

$3.2M Total Retail Price of All Prescriptions

Rank: 12 out of 5176

547 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 25,252 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

58% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$112 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 1,132 1,001 1 16
CRESTOR 769 694 2 15
LOVAZA 734 643 3 43
ATENOLOL 711 635 4 12
METOPROLOL SUCCINATE 671 584 5 11
PLAVIX 639 581 6 29
ADVAIR DISKUS 491 406 7 32
SOLARAZE 471 395 10 8 157
LIDODERM 438 398 9 59
FUROSEMIDE 438 412 9 8
DIOVAN 436 418 11 19
SYNTHROID 431 350 12 33
CELEBREX 422 348 13 80
METFORMIN HCL 419 379 14 7
TAMSULOSIN HCL 412 400 15 20
AZITHROMYCIN 387 331 16 42
AMLODIPINE BESYLATE 365 325 17 2
JANUMET 342 289 18 77
SIMVASTATIN 341 313 19 1
CLOPIDOGREL 333 286 20 26
GLYBURIDE-METFORMIN HCL 327 304 R 21 76
ENALAPRIL MALEATE 323 298 22 22
ZOLPIDEM TARTRATE 321 307 23 17
NAMENDA 312 312 24 47
ATORVASTATIN CALCIUM 288 263 25 9
CREON 287 244 26 111
SINGULAIR 263 174 27 62
CARVEDILOL 260 235 28 24
BENICAR 259 207 29 100
POTASSIUM CHLORIDE 249 234 30 34
LOSARTAN POTASSIUM 247 224 31 14
RANEXA 246 225 32 167
OMEPRAZOLE 243 208 33 3
GLIMEPIRIDE 231 221 34 37
GABAPENTIN 229 200 35 21
LIPITOR 226 209 36 51
LEVOTHYROXINE SODIUM 219 197 37 4
ACTONEL 206 177 38 134
MELOXICAM 202 164 39 53
LANSOPRAZOLE 201 172 40 113
ALENDRONATE SODIUM 194 172 41 18
CILOSTAZOL 194 194 41 206
SPIRIVA 187 156 43 54
MECLIZINE HCL 182 152 44 81
PATANOL 179 165 45 158
LOSARTAN-HYDROCHLOROTHIAZIDE 179 144 45 35
DONEPEZIL HCL 179 168 45 28
JANUVIA 178 158 48 25
VOLTAREN 172 166 49 97
NASONEX 170 139 50 178
METOPROLOL TARTRATE 170 157 50 6
BONIVA 169 156 52 236
WARFARIN SODIUM 160 160 53 13
SERTRALINE HCL 141 130 54 30
ZETIA 140 135 55 68
LEXAPRO 139 133 56 193
ISOSORBIDE MONONITRATE ER 134 129 57 44
SEROQUEL 133 94 58 166
IBANDRONATE SODIUM 130 89 59 211
AMITIZA 129 124 60 197
DIOVAN HCT 125 118 61 39
AVODART 125 124 61 107
AZOR 124 118 63 194
CLOTRIMAZOLE-BETAMETHASONE 123 102 64 94
PROCTOZONE-HC 123 121 64 171
BENICAR HCT 120 103 66 110
LEVOFLOXACIN 119 98 67 109
ZOVIRAX 119 107 10 67 313
NIFEDIPINE ER 114 112 69 48
CITALOPRAM HBR 113 94 70 31
RAMIPRIL 111 109 71 50
DICYCLOMINE HCL 111 94 71 224
ACTOS 110 110 73 85
ESCITALOPRAM OXALATE 107 106 74 89
WELCHOL 102 102 75 230
ABILIFY 101 74 76 273
SINGLE USE SWAB 100 93 77 108
HYDROCHLOROTHIAZIDE 99 96 78 10
ALCOHOL SWABS 98 95 79 115
LANTUS SOLOSTAR 97 91 80 70
AMIODARONE HCL 97 93 80 281
DEXILANT 95 57 82 118
MIRTAZAPINE 94 82 83 45
CYMBALTA 94 93 83 90
LABETALOL HCL 94 90 83 114
RESTASIS 93 67 86 353
QUETIAPINE FUMARATE 93 85 86 75
GLYBURIDE 91 85 R 88 67
LISINOPRIL 90 73 89 5
MOMETASONE FUROATE 86 76 90 251
SYMBICORT 84 81 91 120
LYRICA 82 69 92 133
AMMONIUM LACTATE 80 71 93 91
FLUTICASONE PROPIONATE 79 56 94 38
ALCOHOL PREP PADS 78 69 95 198
CLONIDINE HCL 77 77 96 79
TRAMADOL HCL-ACETAMINOPHEN 75 69 97 116
TRAMADOL HCL 75 62 97 40
FINASTERIDE 74 74 99 69
PROAIR HFA 73 52 100 60
ATELVIA 72 61 101 146
TOPROL XL 71 59 102 227
DETROL LA 71 67 102 249
VESICARE 69 69 104 210
VENTOLIN HFA 69 57 104 64
CICLOPIROX 67 61 106 279
NITROGLYCERIN PATCH 64 61 107 149
MICARDIS 63 54 108 154
PREDNISONE 61 55 109 52
ACETAMINOPHEN-CODEINE 59 53 S3 110 127
TRIBENZOR 59 59 110 276
COMBIVENT 58 50 112 156
LANTUS 54 54 113 66
MICARDIS HCT 53 32 114 180
METOLAZONE 53 49 114 271
DOVONEX 53 42 114 554
DIGOXIN 53 53 114 56
CLOBETASOL PROPIONATE 52 51 118 130
EXELON 52 52 118 162
LACLOTION 52 52 118 299
VENLAFAXINE HCL ER 52 52 118 186
INSULIN SYRINGE 51 49 122 137
TRAZODONE HCL 51 41 122 71
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 122 55
SPIRONOLACTONE 50 50 125 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.